African trypanosomiasis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}}; {{AOEIC}} Pilar Almonacid ; {{ADG}}
{{CMG}}; {{AOEIC}} Pilar Almonacid ; {{ADG}}
==Overview==
==Overview==
If left untreated, the patient will develop symptoms of progressive [[Mental Disorders|mental deterioration]], which is irreversible and eventually lead to death. Common complications that can develop as a result of African trypanosomiasis include [[anemia]], [[aspiration pneumonia]], [[meningoencephalitis]], [[seizures]], [[coma]], [[perinatal death]] or [[abortion]] (congenital infection). The prognosis of [[African trypanosomiasis]] is good with treatment. Without treatment, the mortality rate of African sleeping sickness is close to 100%.<ref name="pmid16157286">{{cite journal |vauthors=Blum J, Schmid C, Burri C |title=Clinical aspects of 2541 patients with second stage human African trypanosomiasis |journal=Acta Trop. |volume=97 |issue=1 |pages=55–64 |year=2006 |pmid=16157286 |doi=10.1016/j.actatropica.2005.08.001 |url=}}</ref><ref name="pmid338269">{{cite journal |vauthors=Levine IM, Jossmann PB, DeAngelis V |title=Liorseal, a new muscle relaxant in the treatment of spasticity--a double-blind quantitative evaluation |journal=Dis Nerv Syst |volume=38 |issue=12 |pages=1011–5 |year=1977 |pmid=338269 |doi= |url=}}</ref>
If left untreated, the patient will develop symptoms of progressive [[Mental Disorders|mental deterioration]], which is irreversible and will eventually lead to death. Common complications that can develop as a result of African trypanosomiasis include [[anemia]], [[aspiration pneumonia]], [[meningoencephalitis]], [[seizures]], [[coma]], [[perinatal death]], or [[abortion]] (congenital [[infection]]). The prognosis of [[African trypanosomiasis]] is good with treatment. Without treatment, the mortality rate of African sleeping sickness is close to 100%.<ref name="pmid16157286">{{cite journal |vauthors=Blum J, Schmid C, Burri C |title=Clinical aspects of 2541 patients with second stage human African trypanosomiasis |journal=Acta Trop. |volume=97 |issue=1 |pages=55–64 |year=2006 |pmid=16157286 |doi=10.1016/j.actatropica.2005.08.001 |url=}}</ref><ref name="pmid338269">{{cite journal |vauthors=Levine IM, Jossmann PB, DeAngelis V |title=Liorseal, a new muscle relaxant in the treatment of spasticity--a double-blind quantitative evaluation |journal=Dis Nerv Syst |volume=38 |issue=12 |pages=1011–5 |year=1977 |pmid=338269 |doi= |url=}}</ref>


==Natural History==
==Natural History==
If [[African trypanosomiasis]] is left untreated, the patient will develop symptoms of progressive mental deterioration, which is irreversible and eventually lead to death.
If [[African trypanosomiasis]] is left untreated, the patient will develop symptoms of progressive mental deterioration, which is irreversible and will eventually lead to death.


==Complications==
==Complications==

Revision as of 19:56, 9 August 2017

African trypanosomiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating African trypanosomiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT Scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

African trypanosomiasis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of African trypanosomiasis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on African trypanosomiasis natural history, complications and prognosis

CDC on African trypanosomiasis natural history, complications and prognosis

African trypanosomiasis natural history, complications and prognosis in the news

Blogs on African trypanosomiasis natural history, complications and prognosis

Directions to Hospitals Treating African trypanosomiasis

Risk calculators and risk factors for African trypanosomiasis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Pilar Almonacid ; Aditya Ganti M.B.B.S. [2]

Overview

If left untreated, the patient will develop symptoms of progressive mental deterioration, which is irreversible and will eventually lead to death. Common complications that can develop as a result of African trypanosomiasis include anemia, aspiration pneumonia, meningoencephalitis, seizures, coma, perinatal death, or abortion (congenital infection). The prognosis of African trypanosomiasis is good with treatment. Without treatment, the mortality rate of African sleeping sickness is close to 100%.[1][2]

Natural History

If African trypanosomiasis is left untreated, the patient will develop symptoms of progressive mental deterioration, which is irreversible and will eventually lead to death.

Complications

Common complications that can develop as a result of African trypanosomiasis include:[1][2]

Prognosis

The prognosis of African trypanosomiasis is good with treatment. Symptoms in both early- and late-stage trypanosomiasis often resolve along with negative parasitemia on repeat blood smears after treatment. The presence of mental status changes and focal neurological deficits is associated with a particularly poor prognosis among patients with African trypanosomiasis. Without treatment, the mortality rate of African sleeping sickness is close to 100%.[1][2]

References

  1. 1.0 1.1 1.2 Blum J, Schmid C, Burri C (2006). "Clinical aspects of 2541 patients with second stage human African trypanosomiasis". Acta Trop. 97 (1): 55–64. doi:10.1016/j.actatropica.2005.08.001. PMID 16157286.
  2. 2.0 2.1 2.2 Levine IM, Jossmann PB, DeAngelis V (1977). "Liorseal, a new muscle relaxant in the treatment of spasticity--a double-blind quantitative evaluation". Dis Nerv Syst. 38 (12): 1011–5. PMID 338269.